|
A more recent version of this article appeared on October 21, 2005
Papers In Press, published online ahead of print August 25, 2005
J. Biol. Chem, 10.1074/jbc.M506460200
Submitted on June 14, 2005
Revised on July 28, 2005
Accepted on August 25, 2005
Cleavage of claspin by caspase-7 during apoptosis inhibits the CHK1 pathway
Catriona A.L. Clarke, Lara N. Bennett, and Paul R. Clarke
Biomedical Research Centre, University of Dundee, Dundee DD1 9SY
Corresponding Author: paul.clarke{at}cancer.org.uk
Claspin is required for the phosphorylation and activation of Chk1 protein kinase by ATR during DNA replication and in response to DNA damage. This checkpoint pathway plays a critical role in the resistance of cells to genotoxic stress. Here, we show that human Claspin is cleaved by caspase-7 during the initiation of apoptosis. In cells, induction of DNA damage by etoposide at first produces rapid phosphorylation of Chk1 by ATR. Subsequently, etoposide causes activation of caspase-7, cleavage of Claspin, and the dephosphorylation of Chk1. In apoptotic cell extracts, Claspin is cleaved by caspase-7 at a single aspartate residue into a large amino-terminal fragment (Claspin-NTF) and a smaller carboxyl terminal fragment (Claspin-CTF) that contain different functional domains. Claspin-NTF is heavily phosphorylated in a human cell-free system in response to double stranded DNA oligonucleotides, and this fragment retains Chk1-binding activity. By contrast, Claspin-CTF does not bind Chk1, but it does associate with DNA and inhibits the DNA-dependent phosphorylation of Chk1 associated with its activation. These results indicate that cleavage of Claspin by caspase-7 inactivates the Chk1 signaling pathway. This mechanism may regulate the balance between cell cycle arrest and induction of apoptosis during the response to genotoxic stress.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. Matsuura, M. Wakasugi, K. Yamashita, and T. Matsunaga
Cleavage-mediated Activation of Chk1 during Apoptosis
J. Biol. Chem.,
September 12, 2008;
283(37):
25485 - 25491.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Verlinden, I. Vanden Bempt, G. Eelen, M. Drijkoningen, I. Verlinden, K. Marchal, C. De Wolf-Peeters, M.-R. Christiaens, L. Michiels, R. Bouillon, et al.
The E2F-Regulated Gene Chk1 Is Highly Expressed in Triple-Negative Estrogen Receptor /Progesterone Receptor /HER-2 Breast Carcinomas
Cancer Res.,
July 15, 2007;
67(14):
6574 - 6581.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Faragher, X.-M. Sun, M. Butterworth, N. Harper, M. Mulheran, S. Ruchaud, W. C. Earnshaw, and G. M. Cohen
Death Receptor-induced Apoptosis Reveals a Novel Interplay between the Chromosomal Passenger Complex and CENP-C during Interphase
Mol. Biol. Cell,
April 1, 2007;
18(4):
1337 - 1347.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Ishii, K. Mimori, H. Inoue, T. Inageta, K. Ishikawa, S. Semba, T. Druck, F. Trapasso, K. Tani, A. Vecchione, et al.
Fhit Modulates the DNA Damage Checkpoint Response
Cancer Res.,
December 1, 2006;
66(23):
11287 - 11292.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|